Differential Ubiquitination as an Effective Strategy Employed by the Blood-Brain Barrier for Prevention of Bacterial Transcytosis

被引:4
|
作者
Bhutda, Smita [1 ]
Ghosh, Sourav [1 ]
Sinha, Akash Raj [1 ]
Santra, Shweta [1 ]
Hiray, Aishwarya [1 ]
Banerjee, Anirban [1 ]
机构
[1] Indian Inst Technol, Dept Biosci & Bioengn, Bacterial Pathogenesis Lab, Mumbai, Maharashtra, India
关键词
Streptococcus pneumoniae; K48-ubiquitination; K63-ubiquitination; autophagy; proteasomal degradation; blood-brain barrier; proteasome; ubiquitin topology; ubiquitination; SELECTIVE AUTOPHAGY; MAMMALIAN-CELLS; RECOGNITION; PROMOTES; MENINGITIS; PROTEINS; INVASION; RECEPTOR; YEAST;
D O I
10.1128/JB.00456-21
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The protective mechanisms of blood-brain barrier (BBB) prohibiting entry of pathogens into central nervous system (CNS) are critical for maintenance of brain homeostasis. These include various intracellular defense mechanisms that are vital to block transcytosis of neurotropic pathogens into the CNS. However, mechanistic details of coordination between these defense pathways remain unexplored. In this study, we established that BBB-driven ubiquitination acts as a major intracellular defense mechanism for clearance of Streptococcus pneumoniae, a critical neurotropic pathogen, during transit through BBB. Our findings suggest that the BBB employs differential ubiquitination with either K48- or K63-ubiquitin (Ub) chain topologies as an effective strategy to target S. pneumoniae toward diverse killing pathways. While K63-Ub decoration triggers autophagic killing, K48-Ub directs S. pneumoniae exclusively toward proteasomes. Timelapse fluorescence imaging involving proteasomal marker LMP2 revealed that in the BBB, the majority of the ubiquitinated S. pneumoniae was cleared by proteasome. Fittingly, inhibition of proteasome and autophagy pathway led to accumulation of K48Ub- and K63-Ub-marked S. pneumoniae, respectively, and triggered significant increases in intracellular S. pneumoniae burden. Moreover, genetic impairment of either K48- or K63-Ub chain formation demonstrated that although both chain types are key in disposal of intracellular S. pneumoniae, K48-Ub chains and subsequent proteasomal degradation have more pronounced contributions to intracellular S. pneumoniae killing in the BBB. Collectively, these observations, for the first time, illustrated a pivotal role of differential ubiquitination deployed by BBB in orchestrating a symphony of intracellular defense mechanisms for interception and degradation of S. pneumoniae, blocking its entry into the brain, which could be exploited to prevent bacterial CNS infections. IMPORTANCE The blood-brain barrier (BBB) represents a unique cellular barrier that provides structural integrity and protection to the CNS from pathogen invasion. Recently, ubiquitination, which is key for cellular homeostasis, was shown to be involved in pathogen clearance. In this study, we deciphered that the BBB deploys differential ubiquitination as an effective strategy to prevent S. pneumoniae trafficking into the brain. The different ubiquitin chain topologies formed on S. pneumoniae dictated the selection of downstream degradative pathways, namely, autophagy and proteasomes, among which the contribution of the proteasomal system in S. pneumoniae killing is more pronounced. Overall our study revealed how the BBB deploys differential ubiquitination as a strategy for synchronization of various intracellular defense pathways, which work in tandem to ensure the brain's identity as an immunologically privileged site.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] From the Blood to the Central Nervous System: A Nanoparticle's Journey Through the Blood-Brain Barrier by Transcytosis
    Fullstone, G.
    Nyberg, S.
    Tian, X.
    Battaglia, G.
    INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 130: NANOTECHNOLOGY AND THE BRAIN, 2016, 130 : 41 - 72
  • [32] A Human Blood-Brain Barrier Transcytosis Assay Reveals Antibody Transcytosis Influenced by pH-Dependent Receptor Binding
    Sade, Hadassah
    Baumgartner, Claudia
    Hugenmatter, Adrian
    Moessner, Ekkehard
    Freskgard, Per-Ola
    Niewoehner, Jens
    PLOS ONE, 2014, 9 (04):
  • [33] The Blood-Brain Barrier
    Gultur, Sefa
    Imir, Gonca
    Tuncer, Ersin
    ERCIYES MEDICAL JOURNAL, 2007, 29 (02) : 147 - 154
  • [34] The Blood-Brain Barrier
    Daneman, Richard
    Prat, Alexandre
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2015, 7 (01):
  • [35] BLOOD-BRAIN BARRIER
    DAVSON, H
    RESEARCH REVIEWS AND CLINICAL TRIALS, 1964, : 96 - &
  • [36] The Blood-Brain Barrier
    Dyrna, Felix
    Hanske, Sophie
    Krueger, Martin
    Bechmann, Ingo
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2013, 8 (04) : 763 - 773
  • [37] BLOOD-BRAIN BARRIER
    BRODIE, BB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 176 (12): : 1063 - &
  • [38] BLOOD-BRAIN BARRIER
    不详
    LANCET, 1961, 2 (721): : 1392 - &
  • [39] The "blood-brain barrier"
    Walter, K
    ZEITSCHRIFT FUR DIE GESAMTE NEUROLOGIE UND PSYCHIATRIE, 1930, 128 (1/4): : 580 - 586
  • [40] BLOOD-BRAIN BARRIER
    DOBBING, J
    PHYSIOLOGICAL REVIEWS, 1961, 41 (01) : 130 - +